Works matching AU D’Alessandria, Calogero

Results: 76

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1765, doi. 10.2967/jnumed.123.265878

By:

Karimzadeh, Amir;
Soeiro, Paula;
Feuerecker, Benedikt;
Hecker, Charlotte-Sophie;
Knorr, Karina;
Heck, Matthias M.;
Tauber, Robert;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

The Impact of PSMA PET--Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen--Targeted Radioligand Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1252, doi. 10.2967/jnumed.122.265346

By:

Karimzadeh, Amir;
Heck, Matthias;
Tauber, Robert;
Solaris, Esteban;
Nekolla, Stephan;
Knorr, Karina;
Haller, Bernhard;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

Safety and Efficacy of [177Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1244, doi. 10.2967/jnumed.122.265259

By:

Tauber, Robert;
Knorr, Karina;
Retz, Margitta;
Rauscher, Isabel;
Grigorascu, Sonia;
Hansen, Kimberley;
D'Alessandria, Calogero;
Wester, Hans-Jürgen;
Gschwend, Jürgen;
Weber, Wolfgang;
Eiber, Matthias;
Langbein, Thomas

Publication type:

Article

Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 896, doi. 10.2967/jnumed.122.264962

By:

Lunger, Lukas;
Chantadisai, Maythinee;
Karimzadeh, Amir;
Rauscher, Isabel;
D’Alessandria, Calogero;
Feuerecker, Benedikt;
Langbein, Thomas;
Tauber, Robert;
Schiele, Stefan;
Weber, Wolfgang;
Eiber, Matthias

Publication type:

Article

177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 402, doi. 10.2967/jnumed.122.264402

By:

Karimzadeh, Amir;
Heck, Matthias;
Tauber, Robert;
Knorr, Karina;
Haller, Bernhard;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

177Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264402

By:

Karimzadeh, Amir;
Heck, Matthias;
Tauber, Robert;
Knorr, Karina;
Haller, Bernhard;
D`Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

177Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264402

By:

Karimzadeh, Amir;
Heck, Matthias;
Tauber, Robert;
Knorr, Karina;
Haller, Bernhard;
D`Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263371

By:

Wurzer, Alexander;
Kunert, Jan-Philip;
Fischer, Sebastian;
Felber, Veronika;
Beck, Roswitha;
de Rose, Francesco;
D'Alessandria, Calogero;
Weber, Wolfgang;
Wester, Hans-Jürgen

Publication type:

Article

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262671

By:

Feuerecker, Benedikt;
Chantadisai, Maythinee;
Allmann, Anne;
Tauber, Robert;
Allmann, Jakob;
Steinhelfer, Lisa;
Rauscher, Isabel;
Wurzer, Alexander;
Wester, Hans-Jürgen;
Weber, Wolfgang A;
d'Alessandria, Calogero;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F‐rhPSMA‐7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D`Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262671

By:

Feuerecker, Benedikt;
Chantadisai, Maythinee;
Allmann, Anne;
Tauber, Robert;
Allmann, Jakob;
Steinhelfer, Lisa;
Rauscher, Isabel;
Wurzer, Alexander;
Wester, Hans-Jürgen;
Weber, Wolfgang A.;
d’Alessandria, Calogero;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F‐rhPSMA‐7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D`Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262671

By:

Feuerecker, Benedikt;
Chantadisai, Maythinee;
Allmann, Anne;
Tauber, Robert;
Allmann, Jakob;
Steinhelfer, Lisa;
Rauscher, Isabel;
Wurzer, Alexander;
Wester, Hans-Jürgen;
Weber, Wolfgang A.;
d’Alessandria, Calogero;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F‐rhPSMA‐7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D`Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1106, doi. 10.2967/jnumed.120.254516

By:

Yusufi, Nahid;
Wurzer, Alexander;
Herz, Michael;
D’Alessandria, Calogero;
Feuerecker, Benedikt;
Weber, Wolfgang;
Wester, Hans-Jürgen;
Nekolla, Stephan;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D'Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D'Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D'Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Detection efficacy of 18F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.260091

By:

Rauscher, Isabel;
Karimzadeh, Amir;
Schiller, Kilian;
Horn, Thomas;
D'Alessandria, Calogero;
Franz, Charlott;
Wörther, Hannah;
Nguyen, Noemi;
Combs, Stephanie E.;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Positive predictive value and correct detection rate of 18F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.255661

By:

Chantadisai, Maythinee;
Buschner, Gabriel;
Krönke, Markus;
Rauscher, Isabel;
Langbein, Thomas;
Nekolla, Stephan G.;
Schiller, Kilian;
Heck, Matthias M.;
Maurer, Tobias;
Wurzer, Alexander;
Wester, Hans-Juergen;
D'Alessandria, Calogero;
Weber, Wolfgang;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D'Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D'Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 0, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D’Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D’Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 0, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D’Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D'Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
Alessandria, Calogero D’;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D'Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D'Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240242

By:

Gafita, Andrei;
Heck, Matthias M.;
Rauscher, Isabel;
Tauber, Robert;
Cala, Lisena;
Franz, Charlott;
D’Alessandria, Calogero;
Retz, Margitta;
Weber, Wolfgang A.;
Eiber, Matthias

Publication type:

Article

Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 6, p. 770, doi. 10.2967/jnumed.118.219105

By:

De Rose, Francesco;
Braeuer, Miriam;
Braesch-Andersen, Sten;
Otto, Angela M.;
Steiger, Katja;
Reder, Sybille;
Mall, Sabine;
Nekolla, Stephan;
Schwaiger, Markus;
Weber, Wolfgang A.;
Bartolazzi, Armando;
D'Alessandria, Calogero

Publication type:

Article

Early Experience of Rechallenge 177Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 644, doi. 10.2967/jnumed.118.215715

By:

Gafita, Andrei;
Rauscher, Isabel;
Retz, Margitta;
Knorr, Karina;
Heck, Matthias;
Wester, Hans-Jürgen;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Tauber, Robert

Publication type:

Article

Modeling and Predicting Tumor Response in Radioligand Therapy.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 1, p. 65, doi. 10.2967/jnumed.118.210377

By:

Kletting, Peter;
Thieme, Anne;
Eberhardt, Nina;
Rinscheid, Andreas;
D’Alessandria, Calogero;
Allmann, Jakob;
Wester, Hans-Jürgen;
Tauber, Robert;
Beer, Ambros J.;
Glatting, Gerhard;
Eiber, Matthias

Publication type:

Article

The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides.

Published in:

Journal of Nuclear Medicine, 2018, v. 59, n. 6, p. 929, doi. 10.2967/jnumed.117.203505

By:

Begum, Nusrat J.;
Thieme, Anne;
Eberhardt, Nina;
Tauber, Robert;
D'Alessandria, Calogero;
Beer, Ambros J.;
Glatting, Gerhard;
Eibery, Matthias;
Klettingy, Peter

Publication type:

Article

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 445, doi. 10.2967/jnumed.116.178483

By:

Shozo Okamoto;
Thieme, Anne;
Allmann, Jakob;
D’Alessandria, Calogero;
Maurer, Tobias;
Retz, Margitta;
Tauber, Robert;
Heck, Matthias M.;
Wester, Hans-Juergen;
Tamaki, Nagara;
Fendler, Wolfgang P.;
Herrmann, Ken;
Pfob, Christian H.;
Scheidhauer, Klemens;
Schwaiger, Markus;
Ziegler, Sibylle;
Eiber, Matthias

Publication type:

Article

Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion.

Published in:

Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1971, doi. 10.2967/jnumed.116.176784

By:

Mendler, Claudia Theresa;
Feuchtinger, Annette;
Heid, Irina;
Aichler, Michaela;
D'Alessandria, Calogero;
Pirsig, Sabine;
Blechert, Birgit;
Wester, Hans-Jürgen;
Braren, Rickmer;
Walch, Axel;
Skerra, Arne;
Schwaiger, Markus

Publication type:

Article

PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 11, p. 1803, doi. 10.2967/jnumed.111.098798

By:

Gourni, Eleni;
Demmer, Oliver;
Schottelius, Margret;
D'Alessandria, Calogero;
Schulz, Stefan;
Dijkgraaf, Ingrid;
Schumacher, Udo;
Schwaiger, Markus;
Kessler, Horst;
Wester, Hans-Jürgen

Publication type:

Article

Radiolabeled Humanized Anti-CD3 Monoclonal Antibody Visilizumab for Imaging Human T-Lymphocytes.

Published in:

Journal of Nuclear Medicine, 2009, v. 50, n. 10, p. 1683, doi. 10.2967/jnumed.108.059485

By:

Malviya, Gaurav;
D'Alessandria, Calogero;
Bonanno, Elena;
Vexler, Vladimir;
Massari, Roberto;
Trotta, Carlo;
Scopinaro, Francesco;
Dierckx, Rudi;
Signore, Alberto

Publication type:

Article

Diagnosis of Vascular Prosthesis Infection: PET or SPECT?

Published in:

Journal of Nuclear Medicine, 2007, v. 48, n. 8, p. 1227, doi. 10.2967/jnumed.107.042002

By:

D'Alessandria, Calogero;
Signore, Alberto;
Burroni, Luca

Publication type:

Article

99m Tc-Interleukin-2 Scintigraphy as a Potential Tool for Evaluating Tumor-Infiltrating Lymphocytes in Melanoma Lesions: A Validation Study.

Published in:

Journal of Nuclear Medicine, 2004, v. 45, n. 10, p. 1647

By:

Signore, Alberto;
Annovazzi, Alessio;
Barone, Raffaella;
Bonanno, Elena;
D'Alessandria, Calogero;
Chianelli, Marco;
Mather, Stephen J.;
Bottoni, Ugo;
Panetta, Chiara;
Innocenzi, Daniele;
Scopinaro, Francesco;
Calvieri, Stefano

Publication type:

Article

Comparative Analysis of Morphological and Functional Effects of 225 Ac- and 177 Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16845, doi. 10.3390/ijms242316845

By:

Feuerecker, Benedikt;
Gafita, Andrei;
Langbein, Thomas;
Tauber, Robert;
Seidl, Christof;
Bruchertseifer, Frank;
Gschwendt, Jürgen E.;
Weber, Wolfgang A.;
D'Alessandria, Calogero;
Morgenstern, Alfred;
Eiber, Matthias

Publication type:

Article

Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.

Published in:

International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 445, doi. 10.3390/ijms19020445

By:

Bartolazzi, Armando;
Sciacchitano, Salvatore;
D’Alessandria, Calogero

Publication type:

Article

Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2041, doi. 10.1007/s00259-024-07003-2

By:

Karimzadeh, Amir;
Hansen, Kimberley;
Hasa, Ergela;
Haller, Bernhard;
Heck, Matthias M.;
Tauber, Robert;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 11, p. 3450, doi. 10.1007/s00259-024-06737-3

By:

Xue, Song;
Gafita, Andrei;
Zhao, Yu;
Mercolli, Lorenzo;
Cheng, Fangxiao;
Rauscher, Isabel;
D'Alessandria, Calogero;
Seifert, Robert;
Afshar-Oromieh, Ali;
Rominger, Axel;
Eiber, Matthias;
Shi, Kuangyu

Publication type:

Article